Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: A STAR*D report

American Journal of Psychiatry

Volumn 164, Issue 5, 2007, Pages 739-752

  Thase, Michael E ^a   Friedman, Edward S ^b   Biggs, Melanie M ^b   Wisniewski, Stephen R ^b   Trivedi, Madhukar H ^b   Luther, James F ^b   Fava, Maurizio ^b   Nierenberg, Andrew A ^b   McGrath, Patrick J ^b   Warden, Diane ^b   Niederehe, George ^b   Hollon, Steven D ^b   Rush, A John ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BUSPIRONE; CITALOPRAM; SERTRALINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COGNITIVE THERAPY; CONTROLLED STUDY; DEMOGRAPHY; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTPATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL; PSYCHOTHERAPY; REMISSION; SOCIOECONOMICS; TREATMENT OUTCOME; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; UNSPECIFIED SIDE EFFECT;

EID: 34249337130     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2007.164.5.739     Document Type: Article

References (62)

1. Depression Guideline Panel: Depression in Primary Care, vol 2: Treatment of Major Depression. Clinical Practice Guideline No 5. AHCPR Publication No 93-0551. Rockville, Md, US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1993
2. Williams JW, Rost K, Dietrich AJ, Ciotti MC, Zyzanski SJ, Cornell J: Primary care physicians' approach to depressive disorders: effects of physician specialty and practice. Arch Fam Med 1999; 8:58-67
3. Thase ME: Bipolar depression: issues in diagnosis and treatment. Harv Rev Psychiatry 2005; 13:257-271
4. Stimpson N, Agrawal N, Lewis G: Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression: systematic review. Br J Psychiatry 2002; 181:284-294
5. Hollon SD, Jarrett RB, Nierenberg AA, Thase ME, Trivedi M, Rush AJ: Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? J Clin Psychiatry 2005; 66:455-468
6. Fava M, Rush AJ: Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice. Psychother Psychosom 2006; 75:139-153
7. Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA, Quitkin FM, Wisniewski S, Lavori PW, Rosenbaum JF, Kupfer DJ: Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Psychiatr Clin North Am 2003; 26:457-494
8. Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, Thase ME, Nierenberg AA, Quitkin FM, Kashner TM, Kupfer DJ, Rosenbaum JF, Alpert J, Stewart JW, McGrath PJ, Biggs MM, Shores-Wilson K, Lebowitz BD, Ritz L, Niederehe G: Sequenced Treatment Alternatives to relieve Depression (STAR*D): rationale and design. Control Clin Trials 2004; 25:119-142
9. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M, STAR*D Study Team: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163:28-40
10. Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M: Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 2006; 354:1231-1242
11. Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ: Medication augmentation after the failure of SSRIs for depression. N Engl J Med 2006; 354:1243-1252
12. Friedman ES, Thase ME: Cognitive-behavioral therapy for depression and dysthymia, in Textbook of Mood Disorders. Edited by Stein DJ, Kupfer DJ, Schatzberg AF. Washington, DC, American Psychiatric Publishing, 2006, pp 353-371
13. Scott J: Chronic depression: can cognitive therapy succeed when other treatments fail? Behavioural Psychotherapy 1992; 20:25-36
14. Thase ME, Friedman ES, Howland RH: Management of treatment-resistant depression: psychotherapeutic perspectives. J Clin Psychiatry 2001; 62(suppl 18):18-24
15. Fava GA, Savron G, Grandi S, Rafanelli C: Cognitive-behavioral management of drug-resistant major depressive disorder. J Clin Psychiatry 1997; 58:278-282
16. McPherson S, Cairns P, Carlyle J, Shapiro DA, Richardson P, Taylor D: The effectiveness of psychological treatments for treatment-resistant depression: a systematic review. Acta Psychiatr Scand 2005; 111:331-340
17. Schatzberg AF, Rush AJ, Arnow BA, Banks PL, Blalock JA, Borian FE, Howland R, Klein DN, Kocsis JH, Kornstein SG, Manber R, Markowitz JC, Miller I, Ninan PT, Rothbaum BO, Thase ME, Trivedi MH, Keller MB: Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Arch Gen Psychiatry 2005; 62:513-520
18. Friedman EF, Thase ME, Biggs MM, Carmin C, Hollon SD, Kornblith SJ, Petersen T, Veenstra G, Wisniewski SR, Rush AJ: The implementation of cognitive therapy in STAR*D. Cognit Ther Res 2004; 28:819-833
19. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994
20. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
21. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278-296
22. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB: The 16-item Quick Inventory Of Depressive Symptomatology (QIDS), Clinician Rating (QIDS-C), and Self-Report (QIDS-SR): a psychometric evaluation inpatients with chronic major depression. Biol Psychiatry 2003; 54:573-583
23. Rush AJ, Bernstein IH, Trivedi MH, Carmody TJ, Wisniewski S, Mundt JC, Shores-Wilson K, Biggs MM, Woo A, Nierenberg AA, Fava M: An evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: a Sequenced Treatment Alternatives to Relieve Depression trial report. Biol Psychiatry 2006; 59:493-501
24. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, Witte B, Kashner TM: The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004; 34:73-82
25. Wisniewski SR, Rush AJ, Balasubramani GK, Trivedi MH, Nierenberg AA: Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract 2006; 12:71-79
26. Wisniewski SR, Eng H, Meloro L, Gatt R, Ritz L, Stegman D, Trivedi M, Biggs MM, Friedman E, Shores-Wilson K, Warden D, Bartolowits D, Martin JP, Rush AJ: Web-based communications and management of a multi-center clinical trial: the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project. Clin Trials 2004; 1:387-398
27. Lavori PW, Rush AJ, Wisniewski SR, Alpert J, Fava M, Kupfer DJ, Nierenberg A, Quitkin FM, Sackeim HA, Thase ME, Trivedi M: Strengthening clinical effectiveness trials: equipoise-stratified randomization. Biol Psychiatry 2001; 50:792-801
28. Shaw BF: Specification of the training and evaluation of cognitive therapists for outcome studies, in Psychotherapy Research: Where We Are and Where We Should Go. Edited by Williams JBW, Spitzer RL. New York, Guilford, 1984, pp 173-189
29. Jarrett RB, Kraft D, Doyle J, Foster BM, Eaves GG, Silver PC: Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial. Arch Gen Psychiatry 2001; 58:381-388
30. Linn BS, Linn MW, Gurel L: Cumulative Illness Rating Scale. J Am Geriatr Soc 1968; 16:622-626
31. Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, Mulsant B, Reynolds CFI: Rating chronic medical illness burden in geropsychiatric practice and research: application of the cumulative illness rating scale. Psychiatry Res 1992; 41: 237-248
32. Zimmerman M, Mattia JI: The reliability and validity of a screening questionnaire for 13 DSM-IV axis I disorders (the Psychiatric Diagnostic Screening Questionnaire) in psychiatric outpatients. J Clin Psychiatry 1999; 60:677-683
33. Rush AJ, Zimmerman M, Wisniewski SR, Fava M, Hollon SD, Warden D, Biggs MM, Shores-Wilson K, Shelton RC, Luther JF, Thomas B, Trivedi MH: Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. J Affect Disord 2005; 87:43-55
34. Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger JE, Burns CT: The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 1986; 18:65-87
35. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH: The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 1996; 26:477-486
36. Rush AJ, Carmody TJ, Reimitz PE: The Inventory of Depressive Symptomatology (IDS): Clinician (IDS-C) and Self-Report (IDS-SR) ratings of depressive symptoms. Int J Methods Psychiatr Res 2000; 9:45-59
37. Fava M, Alpert JE, Carmin CN, Wisniewski SR, Trivedi MH, Biggs MM, Shores-Wilson K, Morgan D, Schwartz T, Balasubramani GK, Rush AJ: Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med 2004; 34:1299-1308
38. Novick JS, Stewart JW, Wisniewski SR, Cook IA, Manev R, Nierenberg AA, Rosenbaum JF, Shores-Wilson K, Balasubramani GK, Biggs MM, Zisook S, Rush AJ: Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. J Clin Psychiatry 2005; 66:1002-1011
39. Khan AY, Carrithers J, Preskorn SH, Lear R, Wisniewski SR, Rush AJ, Stegman D, Kelley C, Kreiner K, Nierenberg AA, Fava M: Clinical and demographic factors associated with DSM-IV melancholic depression. Ann Clin Psychiatry 2006; 18:91-98
40. Mundt JC: Interactive voice response systems in clinical research and treatment. Psychiatr Serv 1997; 48:611-612
41. Kobak KA, Greist JH, Jefferson JW, Mundt JC, Katzelnick DJ: Computerized assessment of depression and anxiety over the telephone using interactive voice response. MD Comput 1999; 16:64-68
42. Endicott J, Nee J, Harrison W, Blumenthal R: Quality-of-Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993; 29:321-326
43. Ware J Jr, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34:220-233
44. Mundt JC, Marks IM, Shear MK, Greist JH: The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry 2002; 180:461-464
45. Fisher L, Dixon D, Herson J, Frankowski R, Hearron M, Peace K: Intention-to-treat in clinical trials, in Statistical Issues in Drug Research and Development. Edited by Ke P. New York, Marcel Dekker, 1990
46. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M: Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163:1905-1917
47. Rush AJ, Beck AT, Kovacs M, Hollon SD: Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients. Cognit Ther Res 1977; 1:17-37
48. Thase ME, Simons AD, Cahalane J, McGeary J, Harden T: Severity of depression and response to cognitive behavior therapy. Am J Psychiatry 1991; 148:784-789
49. Thase ME, Friedman ES, Berman SR, Fasiczka AL, Lis JA, Howland RH, Simons AD: Is cognitive behavior therapy just a "non-specific" intervention for depression? a retrospective comparison of consecutive cohorts treated with cognitive behavior therapy or supportive counseling and pill placebo. J Affect Disord 2000; 57:63-71
50. Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Zajecka J: A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000; 342:1462-1470
51. Hollon SD, DeRubeis RJ, Shelton RC, Amsterdam JD, Salomon RM, O'Reardon JP, Lovett ML, Young PR, Haman KL, Freeman BB, Gallop R: Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry 2005; 62:417-422
52. Thase ME, Dubé S, Bowler K, Howland RH, Myers JE, Friedman E, Jarrett DB: Hypothalamic-pituitary-adrenocortical activity and response to cognitive behavior therapy in unmedicated, hospitalized depressed patients. Am J Psychiatry 1996; 153:886-891
53. Drugs vs talk therapy: 3,079 readers rate their care for depression and anxiety. Consum Rep 2004; 69(10):22-29
54. Gum AM, Arean PA, Hunkeler E, Tang LQ, Katon W, Hitchcock P, Steffens DC, Dickens J, Unutzer J: Depression treatment preferences in older primary care patients. Gerontologist 2006; 46:14-22
55. Jaycox LH, Asarnow JR, Sherbourne CD, Rea MM, LaBorde AP, Wells KB: Adolescent primary care patients' preferences for depression treatment. Adm Policy Ment Health 2006; 33:198-207
56. Lowe B, Schulz U, Grafe K, Wilke S: Medical patients' attitudes toward emotional problems and their treatment: what do they really want? J Gen Intern Med 2006; 21:39-45
57. Bryant MJ, Simons AD, Thase ME: Therapist skill and patient variables in homework compliance: controlling an uncontrolled variable in cognitive therapy outcome research. Cognit Ther Res 1999; 23:381-399
58. Shaw BF, Elkin I, Yamaguchi J, Olmsted M, Vallis TM, Dobson KS, Lowery A, Sotsky SM, Watkins JT, Imber SD: Therapist competence ratings in relation to clinical outcome in cognitive therapy of depression. J Consult Clin Psychol 1999; 67:837-846
59. DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, O'Reardon JP, Lovett ML, Gladis MM, Brown LL, Gallop R: Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005; 62:409-416
60. Jacobson NS, Hollon SD: Cognitive-behavior therapy versus pharmacotherapy: now that the jury's returned its verdict, it's time to present the rest of the evidence. J Consult Clin Psychol 1996; 64:74-80
61. Elkin I, Gibbons RD, Shea MT, Sotsky SM, Watkins JT, Pilkonis PA, Hedeker D: Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of depression Collaborative Research Program. J Consult Clin Psychol 1995; 63:841-847
62. Klein DF, Ross DC: Reanalysis of the National Institute of Mental Health Treatment of Depression Collaborative Research Program General Effectiveness Report. Neuropsychopharmacology 1993; 8:241-251